medigraphic.com

2006, Number 1

<< Back Next >>

Cir Cir 2006; 74 (1)

Prevalence of premature retinopathy. 12-year detection in hospital “20 de Noviembre”

Orozco-Gómez LP, Ruiz-Morfín I, Lámbarry-Arroyo A, Morales-Cruz MV

Language: Spanish
References: 37
Page: 3-9
PDF size: 130.46 Kb.


ABSTRACT

Background: We undertook this study to determine the prevalence of premature retinopathy in a third level care hospital.
Methods: We carried out a descriptive, observational, longitudinal and prospective study from March 1991 to February 2004, including newborns with low birthweight of ‹1500 g and ‹35 weeks of gestation, evaluating the peripheral retina under pharmacological midryasis weekly during 4 weeks starting the 4th week of extrauterine life. The ROP international classification was used.
Results: Within our 12-year study, 2558 children were born, 62% were full term and 38% were premature. From 735 live premature births, 170 fulfilled inclusion criteria: 42% (72) did not present changes regarding retinopathy with a prevalence of 9.79, 46% (78) were in stages I-III with a prevalence of 10.61, and 12% (20) were in umbral stage with a prevalence of 2.72%.
Conclusions: The prevalence of premature retinopathy in a third level hospital was 10.61% in stages I-III and 2.72% in umbral stage. This has allowed the evaluation of the peripheral retinal and the ability to plan treatment in the umbral stage to prevent future complications of blindness from disease progression in these cases.


REFERENCES

  1. American Academy of Pediatrics Society. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 1997;100:273.

  2. Yannuzzi LA, Guyet DR, Green WR. Retinopathy of prematurity. In: Yannuzzi LA, Guyet DR, Green WR, eds. The Retina Atlas. St. Louis, MO: Mosby;1996. pp. 470-479.

  3. Vitreoretinal Course 1997, Bascom Palmer Institute, Miami, FL. CD ROM;1997.

  4. Terry TL. Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens: preliminary report. Am J Ophthalmol 1942;25:203-204.

  5. Todd D J. Retinopathy of premature in infants less than 32 weeks’ gestation at birth in New South Wales in 1993-1994. Ped Child Health 1999;35(4):355-357.

  6. Schulemburg WE, Prendiville A. Natural history of retinopathy of prematurity. Br J Ophthalmol 1987;71:837-843.

  7. Flynn JT, Balacari E, Bachynski BN. Retinopathy of prematurity: diagnosis, severity and natural history. Ophthalmology 1987;94:620-629.

  8. Cats BP, Tan KE. Retinopathy of prematurity: review of a four year period. Br J Ophthalmol 1985;69:500-503.

  9. Valentine PH, Jackson JC. Increased survival of low birth weight infants: impact on the incidence of retinopathy of prematurity. Pediatrics 1989;84:442-445.

  10. Palmer EA, Flynn JT. Incidence and early course of retinopathy of prematurity. Ophthalmology 1991;98:1628-1640.

  11. Nissenkorn I, Kremer I, Gilad E. “Rush” type retinopathy of prematurity: report of three cases. Br J Ophthalmol 1987;71:559-562.

  12. York JR. Landers S. Kirby RS. Arbogast PG. Penn JS. Arterial oxygen fluctuation and retinopathy of prematurity invery-low-birth-weight infants. J Perinatol 2004;24(2):82-87.

  13. Schaffer DB, Palmer EA. Prognostic factors in the natural course of retinopathy of prematurity. Ophthalmology 1993;100:230-237.

  14. McColm JR, Cunningham S, Wade J, Sedowofia K, Gellen B, Sharma T, McIntosh N, Fleck BW. Hypoxic oxygen fluctuations produce less severe retinopathy than hyperoxic fluctuations in a rat model of retinopathy of prematurity. Pediatr Res 2004;55(1):107-113.

  15. Lucey JF, Dangman B. A reexamination of the role of oxygen in retrolental fibroplasia. Pediatrics 1984;73:82-96.

  16. Patz A, Hoeck LE. Studies on the effect of high oxygen administration in retrolental fibroplasia. Am J Ophthalmol 1952;35:1248-1253.

  17. Kretzer FL, Menta RS, Johnson AT. Vitamin E protects against retinopathy of prematurity through action on spindle cells. Nature 1984;309:793-795.

  18. Johnson L, Quinn GE, Abbasi S, Gerdes J, Bowen FW, Bhutani V. Severe retinopathy of prematurity in infants with birth weights less than 1250 grams: incidence and outcome of treatment with pharmacological serum levels of vitamin E in addition to cryotherapy from 1985 to 1991. J Pediatr 1995;127:632-638.

  19. Tasman W, Brown GC. Cryotherapy for active retinopathy of prematurity. Ophthalmology 1986;93:580-585.

  20. Allegaert K, Van de Velde M, Casteels I, Naulaers G, Vanhole C, Devlieger H. Cryotherapy for threshold retinopathy: perioperative management in a single center. Am J Perinatol 2003;20(5):219-226.

  21. Tasman W. Ten-year follow-up from the CRYO-ROP study. Arch Ophthalmol 2001;119(8):1200-12001.

  22. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: Ophthalmological outcomes at 10 years. Multicenter Study. Randomized Controlled Trial. Arch Ophthalmol 2001;19(8):1110-1118.

  23. Ben-Sira I, Nissenkom I. Long term results of cryotherapy for active stages of retinopathy of prematurity. Ophthalmology 1986; 3:1423-1428.

  24. Fledelius HC. Retinopathy and myopia of prematurity. Br J Ophthalmol 2000;4(8):937.

  25. Hunter DG, Repka MX. Diode laser photocoagulation for threshold retinopathy of prematurity. Ophthalmology 1993;00:238-244.

  26. Capone A, Díaz-Rohena R. Diode laser photocoagulation for zone 1 threshold retinopathy of prematurity. Am J Ophthalmol 1993; 16: 444-450.

  27. Landers MB III, Toth CA. Treatment of retinopathy of prematurity with argon laser photocoagulation. Arch Ophthalmol 1992;110:44-47.

  28. Sneed SR, Pulido JS. Surgical management of late-onset retinal detachments associated with regressed retinopathy of prematurity. Ophthalmology 1990;97:179-183.

  29. Coats DK. Miller AM. Brady McCreery KM. Holz ER. Paysse EA. Involution of threshold retinopathy of prematurity after diode laser photocoagulation. Ophthalmology 2004;111(10):1894-1898.

  30. De Juan E, Machemer R. Retinopathy of prematurity: surgical technique. Retina 1987;7:63-69.

  31. Schepens CL. Clinical and research aspects of subtotal open-sky vitrectomy. Arch Ophthalmol 1981;91:143-144.

  32. González-Urquidi, De la Fuente-Torres M. Incidencia de la retinopatía del prematuro en el Hospital Dr. Manuel Gea González. Rev Mex Oftalmol 2004;78(1):1-4.

  33. Phelps DL. Retinopathy of prematurity: an estimate of visual loss in the United States, 1979. Pediatrics 1981;67:924-925.

  34. Dutta S, Narang S, Narang A, Dogra M, Gupta A. Risk factors of threshold retinopathy of prematurity. Indian Pediatr 2004;41 (7):665-671.

  35. Wagner RS. Increased incidence and severity of retinopathy of prematurity in developing nations. J Pediatr Ophthalmol Strabismus 2003;40(4):193.

  36. Shih SC, Ju M, Liu N, Smith LE. Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity. J Clin Invest 2003;112(1):50-57.

  37. Pérez-Pérez JF. Retinopatía del prematuro. Rev Mex Oftalmol 1999; 73(1):33-40.




2020     |     www.medigraphic.com